Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation (original) (raw)
References
Prineas, J.W. & McDonald, W.I. Demyelinating diseases. in Greenfield's Neuropathology, 6th edn. (eds. Graham, D.I. & Lantos, P.L.) 813–896 (Arnold, London 1997). Google Scholar
Raine, C.S. Demyelinating diseases. in Textbook of Neuropathology 3rd edn. (eds. Davis R.L. and Robertson, D.M.) 243–287 (Williams & Wilkins, Baltimore, 1997). Google Scholar
Wolswijk, G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci.18, 601–609 (1998) ArticleCAS Google Scholar
Chang, A., Tourtellotte, W.W., Rudick, R. & Trapp, B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med.346, 165–73 (2002) Article Google Scholar
Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Cho, E.S. & Sharer, L.R. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab. Invest.63, 624–636 (1990) CASPubMed Google Scholar
Brosnan, C.F. & Raine, C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol.6, 243–257 (1996). ArticleCAS Google Scholar
Ohtsuka, T. et al. Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation. EMBO J.18, 2196–2207 (1999). ArticleCAS Google Scholar
Wang, S. et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron21, 63–75 (1998). Article Google Scholar
Kondo, T. & Raff M.C. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development127, 2989–2998 (2000). CAS Google Scholar
Givogri, M.I. et al. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J. Neurosci. Res.67, 309–320 (2002). ArticleCAS Google Scholar
Raine, C.S. The neuropathology of multiple sclerosis. in Multiple Sclerosis: Clinical and Pathogenetic Basis (eds. Raine, C.S., McFarland, H.F. & Tourtelotte, W.W.) 151–172 (Chapman & Hall, London, UK, 1997). Google Scholar
Baranzini, S.E. et al. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol.165, 6576–6582 (2000). ArticleCAS Google Scholar
Cannella, B. & Raine, C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol.37, 424–435 (1995). ArticleCAS Google Scholar
Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med.8, 500–508 (2002). ArticleCAS Google Scholar
McCartney-Francis, N.L., Frazier-Jessen, M. & Wahl, S.M. TGF-β: A balancing act. Int. Rev. Immunol.16, 553–580 (1998). ArticleCAS Google Scholar
Blobe, G.C., Schiemann, W.P. & Lodish, H.F. Role of transforming growth factor β in human disease. N. Engl. J. Med.342, 1350–1358 (2000). ArticleCAS Google Scholar
Lee, S.C. & Brosnan, C.F. Molecular biology of glia: Astrocytes. in Molecular Biology of Multiple Sclerosis (ed. Russell, W.C.) 71–96 (John Wiley & Sons, New York, 1997). Google Scholar
Luster, A.D. & Ravetch, J.V. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med.166, 1084–1097 (1987) ArticleCAS Google Scholar
Gray, G.E. et al. Human ligands of the Notch receptor. Am. J. Pathol.154, 785–794 (1999). ArticleCAS Google Scholar
Bottinger, E.P. et al. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc. Natl. Acad. Sci. USA93, 5877–5882 (1996). ArticleCAS Google Scholar
McDonald, W.I. & Sears, T.A. Effect of demyelination on conduction in the central nervous system. Nature221, 182–183 (1969). ArticleCAS Google Scholar
Smith, K.J., Blakemore, W.F. & McDonald, W.I. Central remyelination restores secure conduction. Nature280, 395–396 (1979). ArticleCAS Google Scholar
Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med.338, 278–285 (1998). ArticleCAS Google Scholar
Logan, A. et al. Effects of transforming growth factor β1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci.6, 355–363 (1994). ArticleCAS Google Scholar
Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature359, 693–699 (1992). ArticleCAS Google Scholar
_estan, N., Artavanis-Tsakonas, S. & Rakic, P. Contact-dependent inhibition of cortical neurite growth mediated by Notch signaling. Science286, 741–746 (1999). Article Google Scholar
Redmond, L., Oh, S.-R., Hicks, C., Weinmaster, G. & Ghosh, A. Nuclear Notch1 signaling and the regulation of dendritic development. Nature Neurosci.3, 30–40 (2000). ArticleCAS Google Scholar
Liu, J.S.H., Zhao, M-L., Brosnan, C.F. & Lee, S.C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: Role of IL-1β and IL-1 receptor antagonist. J. Immunol.157, 3569–3576 (1996). CASPubMed Google Scholar
Stears, R.L., Getts, R.C. & Gullens, S.R. A novel, sensitive detection system for high-density microarrays using dendrimer technology. Physiol. Genomics3, 93–99 (2001). Article Google Scholar
Lassmann, H., Raine, C.S., Antel, J. & Prineas, J.W. Immunopathology of multiple sclerosis: Report on an international meeting at the Institute of Neurology at the University of Vienna. J. Neuroimmunol.86, 213–217 (1998). ArticleCAS Google Scholar
Wu, E. & Raine, C.S. Multiple sclerosis: Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab. Invest.67, 88–99 (1992). CASPubMed Google Scholar